Adam Lezack - Jan 29, 2025 Form 3 Insider Report for Beta Bionics, Inc. (BBNX)

Role
Director
Signature
/s/ Stephen Feider, Attorney-in-Fact
Stock symbol
BBNX
Transactions as of
Jan 29, 2025
Transactions value $
$0
Form type
3
Date filed
1/29/2025, 09:38 PM
Next filing
Feb 3, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BBNX Director Stock Option (right to buy) Jan 29, 2025 Class B Common Stock 9.14K $5.10 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest in 36 equal monthly installments measured from December 12, 2023.
F2 In accordance with the Issuer's Amended and Restated Certificate of Incorporation, the Issuer's outstanding shares of Class B Common Stock will convert into an equal number of shares of Common Stock immediately prior to the closing of the initial public offering.